| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Dentsply Sirona (NASDAQ:XRAY) lowers FY2025 Adj EPS guidance from $1.80-$2.00 to $1.60 vs $1.88 analyst estimate. Affirms FY202...
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0....
UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $24 to $23.
On October 14, 2025, DENTSPLY SIRONA Inc. (the "Company") announced that the Division of Enforcement of the Securities ...
Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a In-Line and lowers the price ta...